P3 Health Partners Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 342.84 million compared to USD 254.03 million a year ago. Revenue was USD 346.86 million compared to USD 258.21 million a year ago. Net loss was USD 25.46 million compared to USD 94.03 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 2.26 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 2.26 a year ago.

For the full year, the company reported sales was USD 1,252.31 million compared to USD 1,034.8 million a year ago. Revenue was USD 1,266.38 million compared to USD 1,049.47 million a year ago. Net loss was USD 57.77 million compared to USD 270.13 million a year ago. Basic loss per share from continuing operations was USD 0.61 compared to USD 6.5 a year ago. Diluted loss per share from continuing operations was USD 0.63 compared to USD 6.5 a year ago.